BSE: BIOCON - Biocon Limited

Rentabilité sur six mois: +5.38%
Rendement en dividendes: +0.42%

Calendrier des promotions Biocon Limited


À propos de l'entreprise Biocon Limited

Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services.

plus de détails
The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.

ISIN INE376G01013
Industry Biotechnology
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.4195
Дивиденд ао 0.5
Сайт https://www.biocon.com
Цена ао 364.8
Changement de prix par jour: +2.1% (364.8)
Changement de prix par semaine: -2.59% (382.35)
Changement de prix par mois: +5.6% (352.7)
Changement de prix sur 3 mois: +5.69% (352.4)
Changement de prix sur six mois: +5.38% (353.45)
Changement de prix par an: +32.57% (280.95)
Evolution du prix sur 3 ans: +3.47% (359.95)
Evolution du prix sur 5 ans: +30.25% (285.95)
Evolution des prix sur 10 ans: 0% (372.45)
Evolution des prix depuis le début de l'année: -1.92% (379.75)

Sous-estimation

Nom Signification Grade
P/S 2.13 7
P/BV 1.19 9
P/E 29.51 6
EV/EBITDA 16.97 6
Total: 7

Efficacité

Nom Signification Grade
ROA, % 1.89 1
ROE, % 5.43 2
Total: 2.17

Dividendes

Nom Signification Grade
Div yield, % 0.4195 1.05
DSI 0.9286 9.29
Total: 2.2

Devoir

Nom Signification Grade
Debt/EBITDA 6.48 0
Total: 3.4

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 125.31 10
Rentabilité Ebitda, % 40.16 6
Rentabilité EPS, % 37.03 5
Total: 5.2

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Siddharth Mittal BCom, CA, CPA MD, CEO & Director 47.88M 1978 (47 années)
Mr. Saurabh Paliwal Head of Investor Relations N/A
Mr. Mayank Verma Company Secretary & Compliance Officer 5.75M
Ms. Seema Shah Ahuja BA, MBA Global Head of Communications & Corporate Brand N/A 1966 (59 années)
Mr. Peter James Jonathan Bains Group Chief Executive Officer 3.28M 1957 (68 années)
Mr. Arun Gupta Head of Operations N/A
Mr. Atanu Roy Group Chief Information Officer N/A
Ms. Maninder Kapoor Puri Head of Human Resources N/A 1973 (52 année)
Dr. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc. Founder & Executive Chairperson 1953 (72 année)
Mr. Mukesh Kamath Chief Financial Officer

Adresse: India, Bengaluru, 20th KM Hosur Road - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.biocon.com